Skip to main content
. 2021 Aug 30;51(4):1841–1848. doi: 10.3906/sag-2011-201

Table 1.

Comparison of variables score ≥ 2 Achilles spurs, score ≥ 2 plantar spurs, and no spur.

Variables* All patients(n = 181) Achilles spurScore ≥ 2(n = 81) Plantar spurScore ≥ 2(n = 81) No spur(n = 22) p* p†
Age, years (mean ± SD) 58.2 ± 14.6 60.5 ± 12.8 63.4 ± 11.7 48.2 ± 17.2 0.004 0.001
Male 147 (81.2) 63 (77.8) 55 (67.9) 20 (90.9) 0.17 0.03
Disease duration, years (median, IQR) 5.1 (4.5) 5.3 (5.1) 5 (4.4) 3.9 (3.8) 0.002 0.008
Duration between gout diagnosis and spur,years (med, IQR) 4.4 (6) 3.6 (6.4)
Uric asid level before the radiograph (mg/dL)(mean ± SD) 8.5 ± 1.8 8.2 ± 1.8 8.3 ± 1.8 8.9 ± 1.8 0.09 0.17
BMI (kg/m2) (mean ± SD) 28.7 ± 4 29.4 ± 4.3 28.6 ± 3.9 27.9 ± 3.8 0.19 0.51
BMI ≥ 30 53 (29.3) 26 (36.6) 21 (31.3) 6 (33.3) 0.89 0.96
Existence metabolic comorbidity 107 (59.1) 56 (69.1) 58 (71.6) 8 (36.4) 0.005 0.002
- Hypertension 87 (48.1) 44 (54.3) 51 (63) 5 (22.7) 0.009 0.001
- Diabetes mellitus 26 (14.4) 14 (17.3) 17 (21) 2 (9.1) 0.35 0.2
- Dislipidemia 20 (11) 8 (9.9) 10 (12.3) 3 (13.6) 0.61 0.87
- Cardiovascular disease 49 (27.1) 22 (27.2) 18 (22.2) 7 (31.8) 0.67 0.35
- Chronic renal disease 20 (11) 11 (13.6) 11 (13.6) 2 (9.1) 0.57 0.57
Overall medical treatment
- Colchicine 180 (99.4) 81 (100) 80 (98.8) 22 (100) 0.99 0.99
- Urat lowering drug 164 (90.6) 73 (90.1) 76 (93.8) 18 (81.8) 0.28 0.09
- Glucocorticoid 77 (42.5) 37 (45.7) 38 (46.9) 7 (31.8) 0.24 0.2